MLYS vs MSFT · $2.17B cap vs P/E 39, rev $331.84B
Mineralys Therapeutics, Inc. Common Stock (MLYS) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
MLYS does not have a complete income-statement cache yet.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
MLYS currently screens at market cap $2.17B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the MLYS and MSFT stock pages for the full models.
Not investment advice.